Lataa...
Recombinant activated factor VII as treatment for uncontrolled mucosal haemorrhage
We report the use of a haemostatic drug (recombinant activated factor VII (rFVIIa)) in a patient who presented a slow but constant bleed in oesophageal mucosa (which required frequent red blood cell transfusion) due to ingestion of caustic products. The administration of rFVIIa ceased bleeding and a...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3128341/ https://ncbi.nlm.nih.gov/pubmed/22693200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr.09.2009.2306 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|